The Experts below are selected from a list of 4914 Experts worldwide ranked by ideXlab platform

M Pande - One of the best experts on this subject based on the ideXlab platform.

  • Comparative Conjunctival Toxicity of Subconjunctival Preservative-free Gentamicin and Subconjunctival Preservative-free Cefuroxime
    European journal of Implant and Refractive Surgery, 1994
    Co-Authors: A.k. Brahma, M Pande
    Abstract:

    OBJECTIVE: To compare the conjunctival toxicity of subconjunctival injections of preservativefree solutions of gentamicin and cefuroxime. STUDY DESIGN: Prospective study comparing conjunctival Chemosis on the first postoperative day. SETTING: Ophthalmic Department, Harrogate Hospitals, Harrogate, UK. PATIENTS: 52 patients undergoing routine cataract surgery were randomly assigned to receive either subconjunctival injection of gentamicin or cefuroxime at the end of the surgical procedure. MAIN OUTCOME: Incidence and severity of conjunctival Chemosis in the operated eye. RESULTS: No statistically significant difference in the incidence ( P > 0.1) and severity ( P > 0.1) of conjunctival toxicity between the two antibiotics. CONCLUSIONS: There is no difference in the conjunctival toxicity between preservative-free gentamicin and preservativefree cefuroxime.

  • postoperative conjunctival Chemosis in cataract surgery caused by subconjunctival gentamicin injection
    British Journal of Ophthalmology, 1991
    Co-Authors: M Pande
    Abstract:

    A prospective study of 75 patients undergoing cataract surgery was conducted to identify the cause of postoperative conjunctival Chemosis seen in patients with cataracts in this department. The patients were split in three groups of 25 each. Group G patients were given a subconjunctival injection of gentamicin at the end of the cataract procedure; group W patients did not receive subconjunctival gentamicin, but a cellulose wick drain was used during the procedure; and Group GW patients received a subconjunctival injection of gentamicin and a wick drain was also used. The incidence, severity, and the duration of Chemosis were observed in the three groups. Chemosis was seen only in groups G and GW, and the difference between the number of patients who received gentamicin and those who did not receive gentamicin was significant (p less than 0.001).

Vasileios C Kyttaris - One of the best experts on this subject based on the ideXlab platform.

John D Gottsch - One of the best experts on this subject based on the ideXlab platform.

  • Chemosis as a presenting sign of systemic lupus erythematosus
    Archives of Ophthalmology, 1992
    Co-Authors: Alan B Leahey, Thomas B Connor, John D Gottsch
    Abstract:

    Conjunctival edema or Chemosis is a common physical finding in many diseases. It has been described with local infections, inflammations, allergies, chemical burns, retrobulbar hemorrhage, trauma, drug use, glandular fever, meningitis, dacrocystitis, styes, insect bites, vaccinal pocks, orbital inflammation or infection, orbital tumors or cysts, blockage of lymphatic veins, angioneurotic edema, Graves' disease, anemia, heart failure, nephrotic conditions, sinusitis, myxedema, premenstrual phase of water retention, carotid-cavernous fistula, thrombosis of cavernous sinus, congenital conjunctival lymphedema, Quincke edema fugax, erysipelas, and lymphogranuloma venereum. 1 There is one reported case of Chemosis as the initial manifestation of systemic lupus erythematosus (SLE). However, that patient had a nephrotic syndrome secondary to SLE. 2 We report a case of Chemosis as a presenting sign of SLE in a patient without renal involvement. Report of a Case. —A 36-year-old white woman with a 3-month history of Chemosis and periorbital edema of both eyes presented at the

Utako Okushiba - One of the best experts on this subject based on the ideXlab platform.

  • transient myopia with severe Chemosis as an initial manifestation of systemic lupus erythematosus
    Modern Rheumatology, 2001
    Co-Authors: Toshiyuki Bohgaki, Masaya Mukai, Atsushi Notoya, Makoto Kondo, Michifumi Kohno, Utako Okushiba
    Abstract:

    A 24-year-old woman suffered from blurred vision and periorbital edema with remittent fever. She was diagnosed as having systemic lupus erythematosus (SLE), complicated with myopia and retinopathy and severe Chemosis. Antiphospholipid syndrome (APS), hemophagocytic syndrome, and liver involvement were also proven. We considered that APS might cause Chemosis as a result of thrombosis-induced perfusion failure in the conjunctiva. In such cases, APS should be considered and anticoagulation therapy associated with steroid therapy should be initiated. In systemic lupus erythematosus (SLE), Chemosis, severe hepatitis, and hemophagocytic syndrome (HPS) are rare complications. It is well known that many cases of SLE are complicated with antiphospholipid syndrome (APS), which causes arteriovenous thrombosis. We report a case of SLE with transient myopia and severe Chemosis complicated with severe hepatitis and HPS. As this patient had antiphospholipid antibodies, these ocular complications were considered to be related to APS.

Vasileios G Peponis - One of the best experts on this subject based on the ideXlab platform.